Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome-Reference-Cited by-同舟云学术

Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome

Published:2023-05 Issue:5 Volume:13 Page:2176-2187
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Hu Chuan,Song Yujun,Zhang Yiwei,He Siqin,Liu Xueying,Yang Xiaotong,Gong Tao,Huang Yuan,Gao Huile

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference45 articles.

1. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies;Galon;Nat Rev Drug Discov,2019

2. The tumor microenvironment in the response to immune checkpoint blockade therapies;Petitprez;Front Immunol,2020

3. Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy;Peng;Adv Sci,2022

4. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy;Xu;Acta Pharm Sin B,2022

5. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations;Zou;Sci Transl Med,2016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in tumor stroma-based targeted delivery;International Journal of Pharmaceutics;2024-10

2. GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor;Journal of Nanobiotechnology;2024-09-05

3. Coacervation‐Driven Semipermeable Nanoreactors for Enzymatic Cascade‐Mediated Cancer Combination Therapy with Enhanced Efficacy;Advanced Materials;2024-09-05

4. Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression;Acta Pharmaceutica Sinica B;2024-09

5. Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy;Acta Pharmaceutica Sinica B;2024-09